Merkel cell carcinoma (MCC) is a rare, clinically aggressive, cutaneous neuroendocrine (NE) neoplasm. As a tumor with small, round, blue cells, the histologic differential diagnosis for MCC can include melanoma, metastatic small cell carcinoma (SCC), nodular hematopoietic tumors, basal cell carcinoma (BCC), atypical variants of squamous carcinoma and the uncommon occurrence of primary cutaneous Ewing sarcoma. In cases with atypical histology or without the classic immunophenotype, the diagnosis can be challenging. Ultimately, immunohistochemistry (IHC) is essential to the definitive diagnosis of MCC and in difficult cases, the diagnosis may hinge entirely on the immunophenotype of the tumor cells.
| INTRODUCTION
Merkel cell carcinoma (MCC), also referred to as cutaneous neuroendocrine (NE) carcinoma, is a rare, clinically aggressive, primary NE neoplasm of the skin. Clinically, MCC is typically a tumor of the elderly that shows a predilection for sun-exposed skin. 1 MCCs do not possess a pathognomonic clinical appearance; consequently, MCC is infrequently suspected at the time of biopsy. 2 Lesions often present as a rapidly growing, asymptomatic, solitary, erythematous to fleshcolored papule, nodule, or plaque that is uncommonly ulcerated. 3 MCC is characterized by a histologic appearance and immunophenotype similar to NE neoplasms of other tissues and was first described by pathologist Cyril Toker in 1972 as "trabecular carcinoma" due to a commonly seen histologic pattern. Despite being a recognized entity for over 40 years, the cell of origin of these tumors remains the subject of some debate. Originally thought to arise from native neuroregulatory cells within the skin (Merkel cells, after 19th century anatomist and histopathologist, Friedrich Merkel), [4] [5] [6] [7] more recent work suggests the tumor cells may instead originate from multipotent stem cells, or develop from some contribution of virally infected dermal fibroblasts. 8, 9 Irrespective of the cell of origin, the molecular pathogenesis of MCC is thought to be driven by clonally integrated Merkel cell polyomavirus (MCPyV) in a significant proportion of cases. 9 The presence of MCPyV often provides a useful diagnostic adjunct. 
| MATERIALS AND METHODS
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| RESULTS
Patients had a mean age at diagnosis of 71.6 (range: 61-89), and a male predilection of 6.5 to 1 (Table 1) Previous work has showed that INSM1 is a highly specific pan-NE marker. 18 In order to more thoroughly examine the specificity of c This poorly differentiated carcinoma was negative for CK20, TTF1, S100, EMA, CD3, CD20, CD31 and CD68, but showed strong diffusely positive staining for AE1/AE3. Previous work has showed that INSM1 is highly specific to NE tissue, and in the adult is largely specific to NE neoplasms. 26, 27, 55 We confirm this finding in cutaneous tissue, observing no significant staining in non-NE tissues and neoplasms. Importantly, there was no significant staining in cases which might lead to diagnostic confusion, including melanoma, hematolymphoid neoplasms (SLL) and basaloid epidermal neoplasms. In contrast, INSM1 was readily detectable in MCC and other NE neoplasms, including metastatic high-grade NE carcinoma (preauricular and parotid gland lymph node) and EMPSGC (from the inner canthus).
CK20 expression in MCC often helps to resolve potential diagnostic confusion between MCC and other NE neoplasms. 5, 56, 57 In this series, CK20 expression was indeed absent from metastatic NE carcinoma and EMPSGC. Interestingly, the single MCC case in which INSM1 could not be detected also lacked staining for CK20, raising the possibility that this lesion may not truly represent MCC. In addition, this neoplasm stained only focally positive for SYP, confirming its NE nature, but was negative for CGA. CK20 negative MCC has been estimated to occur in approximately 3 to 13% of cases of MCC. 5, 13, 57 Some have shown that CK20 negative MCC are more highly correlated with undetectable MCPyV infection, as determined by PCR for large and small T antigens. 1 It is possible that the single INSM1, CK20 negative case in our series represents a non-MCC with NE features (such as a metastatic NE carcinoma from a noncutaneous site). Alternatively, it is also possible that this case represents a CK20 negative MCC and that the unclear pathobiology of MCPyV-negative MCC may correlate with INSM1 expression (or lack thereof ). Up to 20% of MCC lack detectable Merkel cell polyoma virus, 45, [58] [59] [60] and are instead associated with a spectrum of genomic changes possibly related to solar damage. 45, 58, 59, 61, 62 As INSM1 is functionally linked to terminal NE differentiation and to the cell cycle, it is possible that expression of INSM1 will be restricted to cases driven by polyoma virus infection. MCC is relatively uncommon and the current study contains a relatively limited FIGURE 4 INSM1 is expressed in other cutaneous neuroendocrine neoplasms (NENs). As previously reported, INSM1 is detectable by IHC in most NENs, and often in non-NE neoplasms with partial NE differentiation. 45 We 
